You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 2月21日港股收盤

根據uSMART輿情監測數據,21日港股交易時段,市場關注指數最高的5只股票是騰訊控股、聯想集團、海底撈、康希諾生物-B、商湯-W。

2月21日—港股關注排行TOP5

輿情變化榜單

騰訊控股

個股K線圖

關注度第一爲騰訊控股,該股今日收盤下跌5.23%,報於445.40港元。近5個交易日累計下跌5.64%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

恆生指數收跌0.65%報24170點 科技股重挫 騰訊控股跌5.23%

科指跌幅擴至3% 騰訊、快手及嗶哩嗶哩跌幅擴至5.5%-9.5%

聯想集團

個股K線圖

關注度第二爲聯想集團,該股今日收盤上漲5.39%,報於9.00港元。近5個交易日累計上漲2.62%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

聯想集團獲納入恆指 股價漲幅擴大至10%

聯想集團高開逾4% 獲納入恆生指數

海底撈

個股K線圖

關注度第三爲海底撈,該股今日收盤下跌5.54%,報於19.08港元。近5個交易日累計下跌5.07%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

海底撈跌1.19% 預期年度淨虧損38億元-45億元 盈轉虧

預警全年盈轉虧海底撈午後續跌6% 同業反覆跌2%-5%

康希諾生物-B

個股K線圖

關注度第四爲康希諾生物-B,該股今日收盤上漲1.14%,報於142.20港元。近5個交易日累計上漲11.79%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

康希諾生物- B高開8% 重組新型冠狀病毒疫苗獲批用於序貫加強免疫接種

康希諾生物高開8.82% 重組新型冠狀病毒疫苗獲批用於序貫加強免疫接種

商湯-W

個股K線圖

關注度第五爲商湯-W,該股今日收盤上漲6.79%,報於6.61港元。近5個交易日累計上漲0.92%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

科指新貴商湯漲逾7% 被剔除微盟跌逾7%

商湯-W高開3.39% 被納入恆生科技指數和恆生綜合指數

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account